Roche Pays $580M For Biotech Developing Arthritis Treatment
Swiss biotech giant Roche Holding will buy a venture capital-backed company based in California that is developing a treatment for rheumatoid arthritis and other autoimmune and inflammatory diseases in a deal...To view the full article, register now.
Already a subscriber? Click here to view full article